Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 12.2B | 13.3B | 11.7B | 12.0B |
Cost of revenue | 10.3B | 11.3B | 9.9B | 10.2B |
Gross profit | 1.9B | 2.1B | 1.8B | 1.8B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 625M | 662M | 635M | 644M |
Other operating expenses | — | — | — | — |
Operating income | 1.3B | 1.4B | 1.2B | 1.2B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | — | — | — | — |
Other income expense | 21M | 21M | 15M | 18M |
Pretax income | 1.2B | 1.4B | 1.1B | 1.1B |
Tax provision | 206M | 220M | 184M | 185M |
Net income | 994M | 1.1B | 930M | 905M |
Basic EPS | 3.7 | 4.2 | 3.4 | 3.3 |
Diluted EPS | 3.7 | 4.2 | 3.4 | 3.3 |
Basic average shares | 269.0M | 273.4M | 274.4M | 274.1M |
Diluted average shares | 271.7M | 276.9M | 277.9M | 277.7M |
EBITDA | 1.5B | 1.8B | 1.4B | 1.4B |
Net income from continuing op. | 994M | 1.1B | 930M | 905M |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |